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Available online 9 November 2013Abstract We report here that side population (SP) sorting allows for the simultaneous isolation of two intestinal stem cell
(ISC) subsets from wild-type (WT) mice which are phenotypically different and represent cycling and non-cycling pools of cells.
Following 5-ethynyl-2′-deoxyuridine (EdU) injection, in the upper side population (USP) the percentage of EdU+ was 36%
showing this fraction to be highly proliferative. In the lower side population (LSP), only 0.4% of cells were EdU+, indicating this
fraction to be predominantly non-cycling. Using Lgr5-EGFP mice, we show that Lgr5-EGFPhi cells, representing actively cycling
ISCs, are essentially exclusive to the USP. In contrast, using histone 2B-YFP mice, SP analysis revealed YFP label retaining cells
(LRCs) in both the USP and the LSP. Correspondingly, evaluation of the SP fractions for mRNA markers by qRT-PCR showed that
the USP was enriched in transcripts associated with both quiescent and active ISCs. In contrast, the LSP expressed mRNA
markers of quiescent ISCs while being de-enriched for those of the active ISC. Both the USP and LSP are capable of generating
enteroids in culture which include the four intestinal lineages. We conclude that sorting of USP and LSP fractions represents a
novel isolation of cycling and non-cycling ISCs from WT mice.
© 2013 The Authors. Published by Elsevier B.V. All rights reserved.Introduction
The existence of intestinal epithelial stem cells (ISCs) that
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http://dx.doi.org/10.1016/j.scr.2013.10.012(absorptive, goblet, enteroendocrine, Paneth) has been
recognized for the last 40 years (Cheng and Leblond,
1974). There have been recent strides in the characteriza-
tion of both ISC biology, and the niche they occupy (Barker
et al., 2012; King and Dekaney, 2013; Lund, 2012; Noah et
al., 2011). These advances have in large part been a product
of transgenic reporter mice. Information emerging from in
vivo studies of these mice including ISC behavior in normal
physiology, development, cancer, and response to damage,
have shed new light on the existing notion of two distinct ISC
populations or phenotypic states. The crypt base columnar
(CBC) cells, intercalated among Paneth cells in the crypt
base, are rapidly cycling (every 24 h) and display high levelser B.V. All rights reserved.
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lineages (Barker et al., 2007). For this reason, the CBC cells
are referred to as the “active ISC” and are believed to be
primarily responsible for the rapid turnover of the intestinal
epithelium during normal homeostasis (Barker et al., 2012).
Other prominent markers of the actively cycling ISC include
olfactomedin 4 (Olfm4) (Van der Flier et al., 2009a) and
achaete–scute complex homolog 2 (Ascl2) (Van der Flier et
al., 2009b). Located above the Paneth cells in the “+4” cell
position (distributed from +2 to +7) are the long lived, slowly
cycling stem cells (Potten, 1998). Validated genetic markers
of the +4 cell, include polycomb ring finger oncogene (Bmi-1)
(Sangiorgi and Capecchi, 2008), mouse telomerase (mTert)
(Montgomery et al., 2011), homeodomain only protein x
(Hopx) (Takeda et al., 2011), and leucine-rich repeats and
immunoglobulin-like domains protein 1 (Lrig1) (Powell et
al., 2012). The supra-Paneth cells labeled by these markers
have demonstrated the potential to generate the four
main intestinal lineages, and to cycle at higher frequency
following damage (Montgomery et al., 2011; Powell et al.,
2012; Takeda et al., 2011; Yan et al., 2012). The active and
slow-cycling ISC populations appear to be engaged in a fluid
relationship in which +4 cells can generate the CBC pool
(Tian et al., 2011; Yan et al., 2012), and conversely the CBC
can generate the +4 cells in a bidirectional phenomenon
termed interconversion (Takeda et al., 2011). Furthermore,
and in the same vein, it has been proposed that the Lgr5+ cells
express transcripts associated with quiescence (Bmi1, mTert,
Hopx and Lrig1) while maintaining an active status in the
CBC position (Munoz et al., 2012). Adding to this concept of
plasticity, recent publications suggest that committed pro-
genitors or subsets of both Paneth and enteroendocrine cells
may re-enter the cell cycle following damage (Buczacki et al.,
2013; Roth et al., 2012; van Es et al., 2012; Van Landeghem
et al., 2012).
While the various ISC reporter transgenic mice have allowed
for elegant experiments and new insight, this approach is
limited to these specifically-engineered animals and thus
has experimental and therapeutic limitations. In contrast,
fluorescence-activated cell sorting (FACS) approaches using
antibodies against surface markers such as doublecortin-like
kinase 1 (DCLK1), CD24, CD166, and LRIG1 offer the potential
to sort ISC from any mouse or human. However, each of these
antibody-based approaches have caveats of their own: DCLK1 is
expressed on slow-cycling ISC and differentiated tuft cells
(Gerbe et al., 2009), CD24 and CD166 are expressed on
actively-cycling ISC and Paneth cells (Levin et al., 2010; von
Furstenberg et al., 2011), and while Lrig1 is expressed on
slow-cycling ISC, high levels of Lrig1 are expressed in the CBC
(Wong et al., 2012). In light of these caveats a selection
method based on a conserved stem cell property of dye efflux
offers an attractive alternative approach to surface marker
strategies. As indicated above, a major advantage of a
reporter-independent method is that it will facilitate transla-
tion to human tissue. Additionally it will benefit mechanistic
studies of ISC biology: a) by allowing routine experiments on
WT mice, thus avoiding the need for costly procurement and
maintenance of reporter mice; b) and by allowing investigation
of the factors influencing ISC behavior by allowing studies on
existing KO mice (e.g. lacking putative ISC growth factor)
without the need for time-consuming and expensive crossing
of reporter lines to KO lines.The side population (SP) phenotype is due to the presence
of xenobiotic efflux transporters found on the membrane of
stem cells. The technique, originally developed utilizing the
DNA-binding dye Hoechst 33342 (referred to as Hoechst in
this text) with bone marrow cells (Goodell et al., 1996a), has
now been used to successfully isolate stem cells from many
solid tissues including the skeletal muscle, lung, liver, testis,
kidney, skin, mammary gland, heart, and brain (Challen and
Little, 2006). Our laboratory reported in 2005 the use of SP
sorting to enrich for ISC from wild-type (WT) mice (Dekaney
et al., 2005). qRT-PCR of the intestinal SP compared to
intact jejunum revealed enrichment in the ISC marker
Musashi-1 (Msi1) (Dekaney et al., 2005). Interestingly, a
follow-up study using microarray combined with Gene
Ontology analysis found a de-enrichment of transcripts
associated with mitosis in the SP (Gulati et al., 2008). The
same study also validated the SP as originating primarily
from the crypt base by performing in situ for 36 transcripts
enriched in the SP, of which 32 were found to be restricted
to the crypt base.
We hypothesized that the intestinal SP we have previously
reported (Dekaney et al., 2005; Gulati et al., 2008) represents
the slowly-cycling ISC population and that another effluxing
population is apparent above the traditional intestinal SP
(i.e. greater fluorescence of Hoechst blue), newly character-
ized in this publication, which represents the actively cycling
CBC. For the purpose of this paper the traditional SP will be
referred to as the lower SP (LSP) and the newly described
upper SP as USP from here forward as we report a series of
experiments to test this hypothesis. We conclude from these
studies that this one method of SP sorting represents a
valuable contribution to the field because it will allow for the
simultaneous isolation of fractions enriched for actively
cycling and non-cycling ISC simultaneously from WT mice.
Materials and methods
Mice
WT adult male C57BL/6J mice and heterozygote breeder
pairs of Lgr5-EGFP-IRES-creERT2 mice were obtained from
The Jackson Laboratories, and housed under a 12:12-h
light–dark cycle in American Association for Accreditation
of Laboratory Animal Care-approved facilities. All animals
were used within the age range of 6–8 weeks. All WT and
Lgr5-EGFP-IRES-creERT2 animal usage had IACUC approv-
al. Cyp1a1-histone 2B-YFP mice have previously been
described (Lopez-Garcia et al., 2010). Histone 2B-YFP
mice were bred and housed according to UK Home Office
guidelines.
Flow cytometry and FACS
Cell preparation and SP staining/analysis
Epithelial cells were isolated from the jejunum of WT and
Lgr5-EGFP mice using our previous published EDTA method
(von Furstenberg et al., 2011). For SP analysis, cells from the
preparation were incubated in “SP buffer”made with 2% FBS,
and 10 mM HEPES (Life Technologies) in HBSS (Life Technol-
ogies) and either Hoechst 33342 (10 μg/ml equal to 17 μM)
(Sigma-Aldrich) or Vybrant DyeCycle Violet (DCV) 10 μM (Life
366 R.J. von Furstenberg et al.Technologies) for 90 min at 37 °C. Following the incubation,
the cells were washed with ice cold HBSS and labeled with
propidium iodide (Sigma-Aldrich) and CD45-FITC (Biolegend)
at 0.5 μg/106 cells for removal of cells that were dead and/or
of hematopoietic origin. For validation purposes, in order to
block vital dye efflux, cells were pre-incubated with 100 μM
verapamil (Sigma-Aldrich) for 20 min at 37 °C and incubated
with the above SP solution for 90 min at 37 °Cwith the addition
of 100 μM verapamil. To generate the SP fluorescent pheno-
type, Hoechst 33342 samples were excited using a UV laser on aFigure 1 Representative SP plots demonstrating the different flow
gates illustrating the demarcation of the USP and LSP fractions. The
fractions are cleared by verapamil inhibition of the effluxers responMoFlo (Beckman Coulter) fluorescence activated cell sorting
(FACS)machinewhile DCV sampleswere excited using a 405 nm
laser CyAn flow cytometer (Beckman Coulter) or an LSRII flow
cytometer (BD). Corresponding band-pass filter sets were:
MoFlo (blue = 450–50 nm, red = 670-30 nm), CyAn (blue =
450-50 nm, red = 680-20 nm), and LSRII (blue = 450-50 nm,
red = 660-20 nm). On each machine, the SP was defined on the
redlo populationwhichwas eliminated by verapamil (Fig. 1). For
analyses and cell collections, the SP was subdivided into two
regions: upper SP (USP) and lower SP (LSP).cytometer and vital dye combinations utilized in this study with
right-hand panels display corresponding controls in which the SP
sible for the SP phenotype.
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WT mice were injected intraperitoneally with 100 μg EdU
(5-ethynyl-2′-deoxyuridine) in PBS, and sacrificed 1 h
post-injection. The jejunum was harvested and epithelial
cells were isolated, labeled for SP analysis (Hoechst) as
mentioned above, and the LSP and USP fractions of the SP
phenotypewere collected using a MoFlo cell sorter. The LSP and
USP cell collections were then processed for EdU detection
using the Click-it kit (Life Technologies) with an Alexa-647 fluor.
The LSP andUSP cell collectionswere subsequently analyzed for
EdU positivity using a CyAn flow cytometer.
SP & Lgr5-EGFP tracking
Lgr5-EGFP+/− mice were sacrificed, and jejunal epithelial
cells isolated. The cells were incubated and labeled for
SP analysis (DCV) as described above. The cells were then
analyzed using the CyAn to detect both SP fluorescence as
well Lgr5-EGFP signal from the same sample. Summit 4.2
software was used to track the Lgr5-EGFPhi cells with
respect to their SP phenotype.
SP & histone 2B-YFP tracking
Histone 2B-YFP mice were induced by three intraperitoneal
injections of β-naphthoflavone (80 mg/kg) over a 24 h
period. Mice were sacrificed ten days later, and jejunal
epithelial cells isolated using the same technique as above.
Cells were incubated and labeled for SP analysis (DCV) as
described above. Following DCV incubation and washing,
cells were labeled with Ulex europaeus agglutinin I to bind
fucosylated glycoconjugates on Paneth cells (UEA)-Alexa
Fluor 647 (1:1000) (custom conjugation — AbD Serotec),
CD24-PE.Cy7 to label cells from the intestinal crypt base
(1:200) (Biolegend), CD45-Alexa Fluor 647 to exclude cells of
hematopoietic origin, (1:400) (Biolegend) and propidium
iodide for dead cell exclusion (1 μg/ml) (Sigma-Aldrich).
Cells were analyzed on an LSR II flow cytometer and data
analyzed with FlowJo 7.6.
Enteroendocrine cell quantification of SP fractions
The jejunum was harvested and epithelial cells were isolated,
labeled for SP analysis (Hoechst) as described above, and the
LSP and USP fractions of the SP phenotype were collected
using a MoFlo cell sorter. The LSP and USP cell collections were
then permeabilized and labeled with synaptophysin antibody
(Epitomics) as described by Bjerknes and Cheng, with the only
exception being our use of the synaptophysin antibody at an
increased 1:500 concentration (Bjerknes and Cheng, 2010).
Next, the synaptophysin antibody was secondarily labeled
with a DyLight 649 anti-rabbit antibody (Biolegend) at a
1:500 dilution and reanalyzed on the CyAn. To validate the
synaptophysin antibody in our hands it was tested on
intestinal cells isolated from peptide YY-GFP mice, in which
the peptide-YY subset of enteroendocrine cells express GFP
(Bohorquez et al., 2011).
qRT-PCR of SP fractions
LSP and USP were collected into lysis buffer and RNA
isolated using the RNAqueous-Micro kit (Life Technolo-
gies). cDNA was generated using the High Capacity
cDNA Reverse Transcription Kit (Life Technologies).Quantitative reverse transcriptase PCR (qRT-PCR) was con-
ducted for each sample in triplicate. Taqman probes (Actb,
Mm00607939_s1; Dclk1, Mm00444950_m1; Lgr5, Mm00438890_
m1; Lrig1, Mm00456116_m1; mTert, Mm00436931_m1; Ascl2,
Mm01268891_g1; Olfm4, Mm01320260_1; Bmi1 Mm03053308_
g1; Hopx, Mm00558630_m1; SI, Mm01210305_m1; Lyz,
Mm00727183_s1; ChgA Mm00514341_m1; Muc2, Mm00458299_
m1) were obtained from Life Technologies and used according
to manufacturer's protocol. β-Actin RNA was used as an internal
control due to its similar Ct threshold values between USP and
LSP when the same number of cells was collected.
Clonogenic assay and immunohistochemistry
of enteroids
USP and LSP cells were collected using a MoFlo FACS machine
and cultured using a modification of the Sato culture method
in which CHIR99021, a GSK3 inhibitor, is used in place of
recombinant Wnt3a. CHIR99021 has been used successfully
in the growth of intestinal stem cells by activating the Wnt
cascade (de Lau et al., 2011; Ruffner et al., 2012; Wang et al.,
2013). The SP subfractions were pelleted by centrifugation
at 100 ×g and resuspended in matrigel (BD) supplemented
with growth factors to a concentration of 1000 cells/μl and
plated at 10 μl per well in a 48-well plate. Growth factors
were included in the matrigel in the following concen-
trations: Jagged-1 (20 μM) (R&D), EGF (1 μg/ml) (R&D),
Noggin (2 μg/ml) (R&D), R-spondin (10 μg/ml) (R&D),
CHIR99021 (100 μM) (Selleckchem), and Y27632 (200 μM)
(BD). After polymerization of the Matrigel, 200 μl DMEM/F12
media (Invitrogen) supplemented with GlutaMax (1:100)
(Invitrogen), HEPES (10 mM), gentamicin/kanamycin (1:100),
N2 supplement (1:100) (Invitrogen), B27 retinoic acid free
(1:50) (Invitrogen) was added to each well. Media was changed
every 4 days and supplemented with growth factors at 2 days
following replacement with growth factors at a 20-fold lower
concentration than in the initial matrigel plating. Y27632 and
Jagged-1were not added beyond the initial plating. At day 4 the
number of surviving enterospheres in each well was counted in
order to calculate the clonogenic efficiency. At 20 days post
plating, culture media was aspirated, and Matrigel-suspended
enteroids were fixed in 4% paraformaldehyde (PFA) at room
temperature for 20 min. The culture plate was centrifuged at
375 ×g for 2 min, and 4% PFA was carefully aspirated. Enteroids
were then suspended in 30% sucrose at 4 °C for 12 h. The plate
was centrifuged at 375 ×g for 2 min and supernatant was
carefully aspirated. Enteroids were re-suspended in a 5 μl of
30% sucrose and embedded into Optimum Cutting Temperature
(O.C.T.) compound (Sakura-Finetek) and frozen for sectioning.
10 μm enteroid sections were collected onto glass slides.
Sections dried at room temperature and were stored at −
80 °C until time of staining. Enteroid sections were labeledwith
antibodies using the method described by Gracz et al. (2010) to
detect intestinal lineages.
Results
Establishing the USP and LSP
Out of necessity three different machines (Beckman Coulter
MoFlo, Dako CyAn, BD LSRII) and two different vital dyes,
Figure 2 Locating the actively cycling cells with regard to the SP
fractions. C57/BL6 mice were injected with 100 μg EdU. 1 h post
injection, jejunal epithelial cells were isolated and processed for SP
analysis, and the USP and LSP fractions collected (MoFlo/Hoechst).
After collection, the cells were fixed, permeabilized, and the EdU
coupled with a fluor (A647), then reanalyzed for EdU positivity.
(A) The USP was 36 ± 4% EdU positive, (B) while the LSP was 0.4 ±
0.04% EdU positive, n = 3.
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this study to analyze and collect the SP fractions. It has been
previously demonstrated that both Hoechst and DCV SP have
the same membrane pump specificity and generate similar
stem cell populations from mouse hematopoietic cells
(Telford et al., 2007). Using verapamil to block the efflux
transporters, which is the accepted way to define the SP
(Goodell et al., 1996b), we found the LSP and USP fractions
to be in the same orientation using both Hoechst (analyzed
by MoFlo) (Fig. 1A) and DCV (analyzed by CyAn and LSRII)
(Figs. 1B,C). Since DCV is excited by the 405 nm laser which
is commonly equipped on flow cytometers, it serves as a
practical alternative to Hoechst which requires the less
prevalent UV laser for excitation. In the three aforemen-
tioned dye/instrument combinations, the LSP, previously
described as the intestinal SP by our group (Dekaney et al.,
2005), is characterized by a “tail” extending from the
majority non-SP population into the dimmest region of the
red–blue bivariate plot. The USP is visualized above the LSP
along the blue axis, distinguished by its greater blue
fluorescence (Fig. 1). The machine used for analysis or
collection, along with the dye utilized, will be described in
this format (Machine/Dye) within the following subsections.
SP and EdU S phase analysis
To investigate the proliferative activity of the SP fractions, the
USP and LSP were analyzed for 5-ethynyl-2′-deoxyuridine (EdU)
positivity 1 h after injection of WT mice with the thymidine
analog. Because the SP phenotype is reliant on extrusion of vital
dyes by membrane efflux pumps of the ATP-binding cassette
(ABC) transporter superfamily, the collection of the SP fractions
had to be performed before fixation of the cells for EdU
detection. After SP fraction collection (MoFlo/Hoechst), the
fractions were reanalyzed for EdU positivity and displayed a
marked difference. The USP was 36 ± 4% EdU positive upon
reanalysis (Fig. 2A) while the LSP was only 0.4 ± 0.04% EdU
positive (Fig. 2B). These data suggest that the actively cycling
ISCs are likely to reside in the USP. Conversely the paucity of S
phase cells in the LSP, taken along with our group's previous SP
publications, suggests that it may harbor ISC that cycle very
infrequently.
SP & Lgr5-EGFP tracking
Since Lgr5 is a well characterized marker of actively cycling
ISCs (Barker et al., 2007), Lgr5-EGFP-IRES-creERT2 mice
(referred to as Lgr5-EGFP mice from here forward) were
used to assess the distribution of Lgr5+ cells between the USP
and the LSP. To this end, following the SP analysis (CyAn/
DCV) of intestinal epithelial cells from Lgr5-EGFP mice
(Fig. 3A), the Lgr5-EGFPhi fraction was gated forward onto
an SP plot with pre-established USP and LSP gates (Fig. 3C).
Supporting the S phase data from the EdU experiment which
suggested the actively cycling ISC reside in the USP, 96 ± 2%
of the Lgr5-EGFPhi cells fell within the USP gate. In contrast
the LSP contained only 1.3 ± 0.6% of the Lgr5-EGFPhi cells.
Quantitation of the actual Lgr5-EGFPhi contribution to the
overall makeup of the USP was not possible due to the
mosaic expression of Lgr5-EGFP in the intestine of these
mice. Since only a minority of crypts in the Lgr5-EGFP miceactually express EGFP (von Furstenberg et al., 2011), a large
proportion of the EGFP-negative cells in the USP may in fact
be Lgr5+.
SP & histone 2B-YFP LRC tracking
Histone 2B-YFP label retaining cells (YFP-LRCs) identify
quiescent populations in a manner analogous to traditional
nucleotide label retaining assays with the additional bene-
fits of being non-mutagenic and not requiring the cell to
having passed through S-phase in order to be labeled
(Buczacki et al., 2013; Foudi et al., 2009; Hughes et al.,
2012). An initial SP plot was generated (LSRII/DCV) to
establish the USP and LSP gates, (Fig. 4C). YFP-LRCs were
isolated as crypt base, non-Paneth YFP+ cells i.e. CD45−,
UEA−, CD24+ and YFP+ as described in (Figs. 4A,B) using
recently published methods (Buczacki et al., 2013). Forward
gating of YFP-LRCs onto a SP plot demonstrated that 75 ± 6%
of YFP-LRCs fell into the collective SP gates (USP and LSP).
Of those YFP-LRCs in the SP approximately half (54 ± 1.5%)
resided in the LSP and (46 ± 2%) in the USP region (Fig. 4D).
qRT-PCR of SP sub-populations
The experiments to this point suggest that the actively
cycling ISCs are restricted to the USP while the histone
Figure 3 Tracking the Lgr5-EGFPhi cells to the SP fractions. (A) Jejunal epithelial cells were isolated from Lgr5-EGFP mice and
processed for SP analysis (CyAn/DCV) to establish the SP fractions. (B) The “hi” subset (brightest) of Lgr5-EGFP+ cells are actively
cycling ISCs (Sato et al., 2009) and were gated forward onto the pre-established USP and LSP gates. (C) 96 ± 2% Lgr5-EGFPhi cells track
to the USP, while 1.3% were found in the LSP, n = 3.
Figure 4 Distribution of the histone 2B-LRC within the SP. (A) Cartoon illustrating Cyp1a-histone 2B-YFP mouse intestinal crypt
before and after histone 2B-YFP induction with β-naphthoflavone, and consequent washout. (B) Crypt epithelium was isolated 10 d
post injection, and incubated with DCV, anti-CD24 antibody, and UEA. (C) SP fraction gates (LSRII/DCV) were established on the
whole epithelium from histone 2B mouse. Software gating selections were made based on positivity for YFP and anti-CD24 antibody,
and negativity for UEA-A647 and anti-CD45 antibody (not illustrated). 46 ± 2% of YFP-LRCs (single, live, CD45−, UEA−, CD24+, YFP+)
gate forward to the USP and 54 ± 2% to the LSP, n = 3.
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the transcriptional profile of the SP fractions, USP and LSP
were collected (MoFlo/Hoechst) for qRT-PCR with primer/
probes for active and quiescent ISC markers. Additionally
we used primer/probes for the four principal intestinal
lineages to give some insight into the non-stem cell
makeup of the SP fractions.
USP
As expected from the data already presented in Figs. 2 and
3, the USP was enriched in all active ISC markers examinedFigure 5 qRT-PCR analysis of the USP (A) and LSP (B) compared
to intact jejunum for transcripts of active (gray bars) and quiescent
(black bars) ISC, as well as lineages (checkered bars). Active ISC
markers shown include leucine rich repeat containing G protein
coupled receptor 5 (Lgr5), achaete–scute complex homolog 2
(Ascl2), and olfactomedin 4 (Olfm4). Markers of quiescent ISC
examined include leucine-rich repeats and immunoglobulin-like
domains 1 (Lrig1), Bmi1 polycomb ring finger oncogene (Bmi1),
mouse telomerase reverse transcriptase (mTert), HOP homeobox
(HopX), and doublecortin-like kinase 1(Dclk1). Lineage markers
shown: sucrase–isomaltase (SI) [absorptive cell], lysozyme (Lyz)
[Paneth cell], mucin 2 (Muc2) [Goblet cell], and chromogranin A
(ChgA) [enteroendocrine cell]. Bars show mean ± s.e.m., dashed
line represents intact jejunum, and * denotes p b 0.05, n = 5–6.(Fig. 5A), specifically: Lgr5 (25 ± 3), Ascl2 (47 ±16), and
Olfm4 (10 ± 2). Furthermore, in accordance with the
histone 2B-YFP LRC flow cytometric data, the quiescent
ISC associated transcripts were enriched as well: Lrig1
(37 ± 15), Bmi1 (84 ± 15), mTert (39 ± 15), Hopx (13 ± 4),
and Dclk1 (5 ± 2). In regard to lineage positive cells, the
USP was significantly enriched in transcripts for the goblet
cell marker mucin 2 (Muc2) (4.0 ± 1.0), the Paneth cell
marker lysozyme (Lyz) (23 ± 8), and the enteroendocrine
marker chromogranin A (ChgA) (6.3 ±1.7) while being de-
enriched in the absorptive cell marker sucrase isomaltase
(SI) (0.4 ± 0.1).
LSP
The LSP was de-enriched relative to intact jejunum for active
ISC markers, Lgr5 (0.7 ± 0.5), Ascl2 (0.9 ± 0.6), and Olfm4
(0.6 ± 0.5), (Fig. 5B). In contrast, mTert mRNA was signifi-
cantly enriched while other quiescent ISC markers were
increased but did not achieve statistical significance, Lrig1
(4.8 ± 2.2), Bmi1 (9.2 ± 3.9). Dclk1, the quiescent ISC/tuft
cell marker was de-enriched (0.5 ± 0.3). The LSP showed no
venrichment for absorptive, goblet, or Paneth cell transcripts:
SI (1.2 ± 0.1), Muc2 (2.7 ± 1.9), and Lyz (1.0 ± 0.9) respec-
tively, (Fig. 5B). However, the enteroendocrine marker
chromogranin A (ChgA) was elevated in the LSP (17.3 ± 6.6),
(Fig. 5B).
Enteroendocrine cell quantification in SP fractions
In view of the significant enrichment of ChgA mRNA in the
LSP, together with compelling publications implicating this
lineage, or a subset, as a reserve stem cell pool (Sei et al.,
2011; Van Landeghem et al., 2012), we assessed the
prevalence of enteroendocrine cells in our two SPs. As can
be seen in Fig. 6, flow cytometric analysis with antibodies to
the pan-enteroendocrine marker synaptophysin showed
that very few cells in the USP and LSP were synaptophysin
positive (0.3 ± 0.08% and 1.8 ± 0.5% respectively). To validate
the enteroendocrine specificity of the synaptophysin antibody
we tested it against intestinal epithelial cells isolated from the
PYY-GFP mice, developed by Bohorquez et al., in which the
PYY producing subset of enteroendocrine cells express GFP
(Bohorquez et al., 2011). Our resulting flow analysis demon-
strated that almost all PYY-GFP (93.5 ± 1.5%, n = 4) of the
PYY-GFP expressing enteroendocrine subset cells were found
in the synaptophysin positive quadrant, (Supplemental Fig. 1).
Clonogenic assay of SP fractions
Three dimensional Matrigel culture of putative ISC populations
has become a commonly usedmethod to evaluate stemness (Lin
and Barker, 2011). Intestinal stem cell expansion is manifested
first by enterosphere formation and progressing on to a complex
enteroid phenotype as defined by crypt bud genesis resulting in
a multilobular appearance (Stelzner et al., 2012). Both the USP
and the LSP displayed the ability to form enterospheres and
consequent enteroids which were maintained out to 20 days
post plating, at which time they were harvested. Despite the
unique characteristics of the two SP subfractions there was no
apparent difference in morphology between the USP and LSP
outgrowths (Fig. 7A). Moreover there was no significant
Figure 6 Quantifying the percent of enteroendocrine cells in the SP fractions using flow cytometric analysis of
synaptophysin. Cells from the USP and LSP were collected based on SP analysis, fixed, permeabilized, labeled with
synaptophysin antibody and reanalyzed by flow cytometry. The USP and LSP were 0.3 ± 0.08% and 1.8 ± 0.5% synaptophysin
positive, respectively, n = 3.
371Side population sorting separates subfractions of cycling and non-cycling intestinal stem cellsdifference in the efficiency with which the two SP subfractions
generated enterospheres per 10,000 USP or LSP cells plated:
USP (13.7 ± 3.7) and LSP (10.3 ± 0.7), n = 3. Each of the four
intestinal cell lineages (absorptive, goblet, enteroendocrine,
and Paneth) was found in both USP and LSP enteroids as defined
by the respective markers: sucrase-isomaltase, mucin 2,
substance P, and lysozyme (Fig. 7B).Discussion
This paper reports the use of SP sorting to successfully isolate
two phenotypically different putative ISC populations from
WT mice. Most notable is the near 100 fold difference in the
percentage of cells undergoing S-phase when comparing
the LSP to the USP as seen in Fig. 1. Furthermore, we
demonstrated that Lgr5-EGFPhi cells, which represent the
actively cycling ISC (Sato et al., 2009), were found to reside in
the USP when tracked on the SP plot. In contrast, when
tracking the histone 2B-YFP-LRC on an SP plot we found that
the distribution of YFP-LRC was spread between the LSP and
USP with a slight bias to LSP. Upon sorting and processing
the USP and LSP for mRNA analysis, we found differing
transcriptional profiles via qRT-PCR. In support of the
notion that the LSP is characteristic of the slow cycling or
non-cycling ISC pool, mRNA markers associated with
quiescent ISC were enriched, while those of the actively
cycling ISC were de-enriched. The LSP, otherwise free
from lineage transcripts, displayed a high level of ChgA
mRNA. To evaluate the possibility that the LSP contained a
significant proportion of enteroendocrine cells, we employed a
flow cytometric method based on the pan-endocrine marker
synaptophysin (Roth et al., 2012; van Es et al., 2012). The
results showed that less than 2% of the LSP are enteroendocrine
cells. This finding exemplifies the caution that transcript levels,especially from secretory cells, are not necessarily indicative of
cell number (Dehmer et al., 2011; Stahlberg et al., 2011).
The SP phenotype is conferred when a cell expresses
a combination of effluxing membrane proteins belonging
to the ATP-binding cassette (ABC) superfamily including
multi-drug resistance 1 (Mdr1 human, Mdr1a/1b mouse) or
ATP-binding cassette, sub-family G (WHITE), member 2
(Abcg2) also referred to as breast cancer resistance
protein 1 (Bcrp1) which eliminate DNA binding dyes such
as Hoechst 33342 (Challen and Little, 2006) or DyeCycle
Violet (Telford et al., 2007). Despite this efflux, some dye
binds to the DNA and the resulting fluorescence is
determined by DNA content of the cell. The interpretation
of cell cycle activity/DNA content from an SP plot has been
demonstrated with bone marrow cells (Goodell, 2005;
Petriz, 2007) in which a population above the classical SP
(greater blue emission) is actively cycling. Optimizing
instrument settings during our intestinal SP analysis
(Fig. 1) revealed an additional effluxing population (USP)
above the traditional SP (now LSP), which patterned
similar to the bone marrow SP previously mentioned.
Confirming the similarity, we found the USP to be highly
enriched in cells which incorporated EdU following a 1 h
pulse (Fig. 2).
To examine the relationship between the active ISC
population and SP phenotype, we performed SP analysis on
jejunal epithelium from Lgr5-EGFP mice, and found that
almost all Lgr5-EGFPhi cells reside in the USP (Fig. 3).
Unfortunately, as referenced in our results, due to the
mosaicism of Lgr5-EGFP expression in this mouse line, we
could not estimate the total contribution of Lgr5 cells to
the USP. As mentioned in the introduction there are no
published ISC membrane markers which are exclusive to
the active Lgr5- population so we were precluded from
further investigation as to the exact percentage of these
cells in the USP. A further important question awaiting the
Figure 7 Culture of USP and LSP cells in modified Sato conditions. (A) Typical brightfield images depicting growth over 20 days,
with scale as shown. (B) Immunofluorescent staining of enteroids harvested at day 20 for lys (Paneth cells), muc 2 (goblet cells), sub P
(enteroendocrine cells), and SI (absorptive cells).
372 R.J. von Furstenberg et al.development of appropriate approaches is whether the
USP also contains Lgr5-negative cells which have stem cell
properties.
Validating the presence or absence of the slowly cycling ISCs
in the SP regions proved more challenging, primarily because
unlike the Lgr5-EGFP mouse, there is not an equivalent
commercially available mouse with a fluorescent reporter
driven by a promoter that is specific to quiescent ISCs. As an
alternate approach, we utilized a recently described method in
which an inducible fusion protein (histone 2B -YFP) is used to
identify long term label-retaining cells (LRCs) from the
supra-Paneth zone of the mouse intestinal crypt (Buczacki et
al., 2013; Hughes et al., 2012). Using this approach allowed fortracking of the LRC, from the crypt position associated with the
slow cycling ISC (Potten et al., 2002), to an SP plot. As shown in
Fig. 4 the LRCs had a relatively even distribution between the
LSP and USP, slightly more in the LSP. This was not unexpected
because although the LRCs are slow cycling, some portion will
enter, or be in, the cell cycle at any given time (Potten et al.,
2002), putting them in the USP. Such a distribution is consistent
with recent findings from the Mahida laboratory that after a
28 d chase, 38.5% of non-Paneth histone 2B-LRC cells were
cycling as evidenced by Ki-67 staining (Hughes et al., 2012).
Considering differences in experimental technique, their
finding of 38.5% of the LRC in cell cycle, is quite similar to our
46% non-Paneth LRC found in the USP.
373Side population sorting separates subfractions of cycling and non-cycling intestinal stem cellsAnalysis of the transcriptional profiles of the LSP and USP in
terms of ISC markers (quiescent and active) as well as markers
of the epithelial lineages (Fig. 5) provided further evidence
that the LSP and USP are distinct populations. As expected
from the Lgr5-EGFPhi tracking experiment (Fig. 2), we found
an enrichment of the active ISC markers Lgr5, Ascl2, and
Olfm4 in the USP. Interestingly, markers associated with
quiescence (Lrig1, Bmi1, mTert, HopX, and Dclk1) were also
enriched in the USP compared to intact jejunum. This is in
agreement with the recent report that the Lgr5+ cells contain
transcriptional profiles of both active and quiescent ISCs
(Munoz et al., 2012) and with the emerging concept that the
majority of so-called “quiescence markers”, with the possible
exception ofmTert, are not directly related to quiescence per
se rather loosely associated with cell position +4 of the crypt.
The LSP in contrast expressed only the quiescent ISC markers
(Lrig1, Bmi1, mTert, and HopX) at levels above intact
jejunum, and was de-enriched for active ISC transcripts
(Lgr5, Ascl2, and Olfm4). As the latter have been definitively
identified with cycling ISCs, their absence in the LSP may be
considered more informative than the presence of the
quiescent markers. With regard to lineage contamination of
the USP, the levels of Lyz, Muc2, and ChgA transcripts were
increased over intact jejunum. LSP however was relatively
free from contaminating lineage markers with the exception
of the enteroendocrine marker ChgA.
In light of recent publications that a subset of
enteroendocrine cells have ISC potential (Sei et al., 2011; Van
Landeghemet al., 2012), we felt it was important to investigate
the possibility that the LSPwas in fact isolating enteroendocrine
cells. To directly assess the number of enteroendocrine cells in
the SP regions we collected USP and LSP cells from WT
mice and reanalyzed by permeablizing the cells and labeling
with an antibody against the pan-enteroendocrine marker
synaptophysin. The resulting analysis showed less than 2%
of the LSP to be synaptophysin positive indicating the LSP
is likely a different population. The ability of a commit-
ted secretory progenitor to revert back to a stem cell
phenotype following damage has been recently demon-
strated, as in the case of the Dll1hi cell (van Es et al.,
2012) and the histone 2B-LRC secretory progenitor
(Buczacki et al., 2013). The non-cycling status of the
LSP (Fig. 2B) suggests that the Dll1hi progenitor cells are
not included in this fraction. However, as Fig. 4 suggests,
the LSP may be the non-cycling subset of the YFP-LRC
secretory progenitors identified by the Winton lab
(Buczacki et al., 2013).
The matrigel culture assay developed by Sato et al.
(2009) for the evaluation of the intestinal Lgr5-EGFPhi cells
has become a benchmark of stemness for putative ISC
populations (Lin and Barker, 2011). In the current study both
the USP and LSP fractions demonstrated the ability to form
mature enteroids in this culture system. Interestingly, there
was no significant difference in the efficiency with which
they were formed, or apparent difference in outgrowth
morphology. These in vitro similarities were surprising in
light of the absence of cycling cells, and lack of Lgr5-EGFPhi
cells in the LSP. It is possible that the Sato culture method,
being a Wnt-driven system, drives the otherwise quiescent
LSP toward an active ISC phenotype in a rapid manner. Very
similar observations have been made with Bmi1-YFP cells
which are normally quiescent in vivo, but become activatedwhen cultured under Sato conditions (Yan et al., 2012). Just
as suggested by Yan et al. a logical interpretation of our
findings is that in situ, the LSP cells like the Bmi1 cells, are
subjected to inhibitory signals from the ISC niche which are
not present in the culture. Clearly further work will be
needed to explore this scenario.
A recent study that has strengthened the link between
intestinal SP and ISCs is the inducible Abcg2-LacZ mouse model
allowing for lineage tracing (Fatima et al., 2012). Previously
mentioned as one of the vital dye effluxers, Abcg2 has been
demonstrated to be the most critical to the SP phenotype in
bone marrow, because the SP population was eliminated when
the breast cancer resistance protein 1 (Bcrp1), the mouse
homolog of Abcg2, was knocked out (Zhou et al., 2002). Fatima
et al. used adult Abcg2CreERT2/+RosaLacZ/+ treated with tamox-
ifen and found 50% of the crypts and associated villi stained
positive for LacZ one month afterward, with some crypts/villi
remaining positive out to 21 months. This suggests that
intestinal ISCs of varying lifespan express Abcg2. The division
of the SP into an upper and lower portion with respective active
and quiescent phenotypes is a concept already applied in the
hematopoietic stem cell field. Studies from the Goodell lab
identified USP and LSP fractions among hematopoietic stem
cells, with the USP representing more proliferative hematopoi-
etic stem cells with a shorter lifespan and the LSP exhibiting
quiescence and longer life span (Challen et al., 2010). In their
study, the LSP exhibited a higher engraftment rate and
contribution to peripheral blood regeneration than the USP
when transplanted into lethally irradiated mice. While these
studies from the hematopoietic stem cell field are encouraging,
there is still a significant gap to close in our understanding of the
intestinal SP with regard to both therapeutic potential and its
relationship to ISC physiology.
Studies measuring an increase in intestinal SP (LSP)
during development and after challenge have provided
further evidence that the LSP is characteristic of a reserve
ISC population. Mimicking a clinical procedure, Dekaney
et al. investigated jejunal adaption following ileal-cecal
surgical resection in mice (Dekaney et al., 2007). Two to
three days following resection there was a five-fold increase
in the percentage of SP cells, preceding an increase in crypt
fission from 4–7 d post resection. Utilizing a cytotoxic
approach of damaging intestinal epithelium with doxorubi-
cin, SP was found to be initially suppressed, but then surged
ahead of crypt fission during regeneration (Dekaney et al.,
2009). Lastly, in a study of mouse intestinal development
the SP was increased 8-fold at postnatal day 21, a life stage
in which approximately 20% of the intestinal crypts are
fissioning (Dehmer et al., 2011). The coincident timing again
links the increase in SP to a non-homeostatic ISC response.
Together these three published studies, in addition to the
novel data described herein, describe a population (LSP)
which appears to serve as a reserve pool of ISC. While the
LSP increased greatly in response to the stressors mentioned
above (i.e. resection, cytotoxin exposure, and rapid expan-
sion during development), we have demonstrated that under
normal homeostatic conditions the LSP is essentially non-
cycling. Thus, this fraction appears to display characteristics
of a quiescent or reserve ISC population. Unlike genetically
engineered mice, SP analysis offers a valuable tool to isolate
and characterize this reserve fraction of ISC in WT mice and
likely any other species including human.
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